INBX Kronos AI forecast
A 30-trading-day price forecast for Inhibrx Biosciences Inc. (INBX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Inhibrx Biosciences Inc. at $89.48 on 2026-12-08, −6.5% from the last close of $95.66 on 2026-10-27. Eight out of ten sampled paths end between $87.48 and $102.20, and 2 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of INBX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $97.18 | $89.24 | $105.75 |
| 2026-11-10 | $94.79 | $85.61 | $113.57 |
| 2026-11-17 | $94.39 | $89.12 | $115.15 |
| 2026-11-24 | $92.19 | $89.63 | $107.55 |
| 2026-12-01 | $90.09 | $86.69 | $104.94 |
| 2026-12-08 | $89.48 | $87.48 | $102.20 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for INBX?
- Kronos AI's median forecast for INBX is $89.48 in 30 trading days, −6.5% from the last close, with a 10–90% range of $87.48 to $102.20.
- Is the INBX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.